Skip to content Skip to contact
Global Vox Populi

Epidemiology market research company in Tunisia

Understanding Disease Patterns: Epidemiology Research in Tunisia

Tunisia’s pharmaceutical and healthcare sectors are experiencing consistent growth, driven by an expanding population and increasing investment in health infrastructure.

This creates a clear demand for precise data on disease prevalence, treatment pathways, and patient outcomes. Corporate insights managers and healthcare market access leads require this granular view to inform strategic decisions and product development.

Global Vox Populi delivers this critical epidemiology research across Tunisia.

What we research in Tunisia

In Tunisia, our epidemiology research answers core questions about public health and market dynamics.

We quantify disease incidence and prevalence for specific conditions, mapping the patient journey from diagnosis through treatment. Our work tracks treatment patterns, identifying current standards of care and emerging therapies.

We also assess unmet medical needs, revealing gaps in the healthcare system or treatment options.

Also, we conduct studies on the burden of disease, evaluating the economic and social impact of various health conditions. Our research supports brand health assessments for pharmaceutical products and aids in market sizing for new medical devices.

We customize every project scope based on the specific brief, delivering relevant and actionable insights for our clients.

Why Epidemiology market research fits (or struggles) in Tunisia

Epidemiology market research fits well in Tunisia for several reasons. The country has a relatively structured healthcare system, providing accessible data points and a network of healthcare professionals (HCPs) for recruitment.

Urban centers like Tunis, Sfax, and Sousse offer concentrated populations of both patients and specialists, making data collection more efficient. We can effectively reach general practitioners, specialists, and hospital administrators through established channels.

However, challenges exist, particularly in reaching rural populations or highly specific, low-incidence patient groups. Data availability can vary by public versus private healthcare settings.

Language considerations also play a role; while Arabic is the official language, French is widely spoken in medical and business contexts. Our teams are adept at managing these linguistic nuances.

When direct epidemiological data is scarce, we recommend combining our core epidemiology methods with qualitative in-depth interview services in Tunisia to gather richer contextual insights from HCPs and patients.

How we run Epidemiology market research in Tunisia

Our epidemiology research in Tunisia uses a combination of recruitment sources. We access in-country HCP panels and patient registries (where permissible and anonymized), alongside partnerships with local medical associations.

For specific patient populations, we work with patient advocacy groups under strict ethical guidelines. Screening involves rigorous validation checks for professional credentials and patient eligibility. We also implement attention checks and recent-participation flags to maintain data integrity.

Fieldwork formats depend on the research design. This can include online surveys for prevalence studies, CAPI (Computer Assisted Personal Interviewing) for facility-based data collection, or desk research using public health databases.

All fieldwork is conducted in Arabic and French, with native-speaking interviewers and data extractors. Our moderator and interviewer profiles include individuals with backgrounds in health sciences or significant experience in medical research, delivering accurate data capture and interpretation.

Quality assurance touchpoints are integrated throughout the fieldwork. This includes daily checks on data consistency, back-checks on a percentage of completed interviews, and regular debriefs with field teams.

Deliverable formats range from raw, anonymized datasets and detailed methodological reports to interactive dashboards and comprehensive debrief decks. Project management follows a clear cadence, with weekly updates and direct access to your dedicated project lead.

Where we field in Tunisia

Our fieldwork in Tunisia covers all major urban centers and extends into regional areas.

We conduct significant research in the Greater Tunis area, including Tunis, Ariana, and Ben Arous, where much of the country’s healthcare infrastructure is concentrated. Beyond the capital, we regularly field projects in Sfax, Sousse, Kairouan, and Bizerte, which are key economic and population hubs.

For reaching beyond these dominant urban centers, we employ a network of regional field partners and CAPI interviewers. This allows us to access populations in smaller towns and semi-rural areas, delivering representative coverage for national-level studies.

All data collection, whether urban or rural, is conducted fluently in both Tunisian Arabic and French, accommodating the linguistic preferences of respondents.

Methodology, standards, and ethics

Our epidemiology market research adheres strictly to global and local ethical guidelines.

We operate under the ICC/ESOMAR International Code on Market, Opinion and Social Research and Data Analytics (2016 revision) and, where applicable, ISO 20252:2019 standards for market, opinion, and social research.

While a specific local research body in Tunisia like MRSI or MRS is not widely active, we apply ESOMAR principles as a foundational framework for all our operations.

Our epidemiological studies often employ established methodologies such as cross-sectional surveys for prevalence, cohort studies for incidence, and case-control designs for risk factor assessment.

Applying these standards to epidemiology research means making sure informed consent is obtained from all participants, whether patients or healthcare professionals. This consent clearly outlines the purpose of the research, data usage, and anonymity guarantees.

For patient data, we make sure all identifiable information is anonymized or pseudonymized at the point of collection, adhering to strict data minimization principles. We disclose the commercial nature of the research to all respondents, maintaining transparency.

Quality assurance is essential in epidemiological data collection. This involves multiple layers, including peer review of survey instruments and study designs, back-checks on a percentage of completed interviews or data entries, and quota validation to deliver demographic and professional representation.

For quantitative data, we perform statistical validation to identify outliers or inconsistencies, delivering the reliability and accuracy of our findings.

Drivers and barriers for Epidemiology market research in Tunisia

DRIVERS

  • Tunisia’s growing focus on public health initiatives drives demand for epidemiology research.
  • Increased investment in healthcare infrastructure and pharmaceutical innovation encourages studies on disease patterns and treatment efficacy.
  • The country’s expanding digital adoption, particularly among healthcare professionals, supports online survey methodologies.
  • A general willingness among HCPs to participate in research, contributing to medical knowledge, also acts as a significant driver.
  • Post-pandemic shifts have also highlighted the importance of real-time health data.

BARRIERS

  • Several barriers can impact epidemiology research in Tunisia.
  • Language fragmentation, with variations in Arabic dialects and the prevalence of French, requires skilled bilingual teams.
  • Connectivity gaps in some rural regions can complicate online data collection.
  • Reaching specific, low-incidence patient populations or highly specialized HCPs can be challenging, requiring extended recruitment efforts.
  • Regulatory friction, particularly concerning access to sensitive patient data, needs careful navigation to deliver compliance.

Compliance and data handling under Tunisia’s framework

Data handling in Tunisia is governed by Law No. 2004-63 on the Protection of Personal Data. This framework establishes principles for lawful processing, data minimization, and individual rights.

For epidemiology market research, we rigorously apply these principles. Consent capture is explicit and documented, detailing how participant data will be used and protected. We make sure all data residency requirements are met, with data stored on secure servers.

Data retention policies are strictly enforced, making sure data is kept only for the necessary period before secure anonymization or deletion. Anonymization techniques are applied diligently to safeguard participant identities, especially for sensitive health information.

Participants retain withdrawal rights, and we provide clear mechanisms for exercising these. Tell us about your project and we will detail our compliance protocols.

Top 20 industries we serve in Tunisia

  • Pharma & Biotech: Prevalence and incidence studies, treatment pathway mapping, market access for new drugs.
  • Healthcare Providers: Patient experience research, hospital service use, HCP needs assessments.
  • Medical Devices: Adoption rates of new technologies, surgeon preferences, device lifecycle tracking.
  • Government & Public Sector: Public health policy evaluation, disease surveillance, health campaign effectiveness.
  • FMCG & CPG: Health and wellness product perception, dietary habit studies, consumer health awareness.
  • Insurance: Health insurance uptake, chronic disease management program evaluation, policyholder health behaviors.
  • Food & Beverage: Nutritional intake studies, food safety perceptions, public health nutrition initiatives.
  • Agriculture: Zoonotic disease research, food security studies, agricultural worker health.
  • Tourism & Hospitality: Health and safety perceptions for travelers, impact of health crises on tourism.
  • Technology & SaaS: Digital health tool adoption, telemedicine usage, health app effectiveness.
  • Education: Health education program evaluation, student health behaviors, mental health in schools.
  • Telecom: Mobile health (mHealth) service uptake, digital health literacy.
  • Banking & Financial Services: Financial impact of health conditions, health savings trends.
  • Retail & E-commerce: Over-the-counter medication purchasing patterns, health product distribution.
  • Energy & Utilities: Environmental health impact assessments, worker safety studies.
  • Automotive & Mobility: Road safety research, injury epidemiology, public transport health considerations.
  • Real Estate: Health impact of urban planning, healthy building design preferences.
  • Media & Entertainment: Health information consumption patterns, public health messaging effectiveness.
  • Apparel & Fashion: Health implications of specific materials, ergonomic product design.
  • NGO & Development: Disease prevention program evaluation, health intervention impact assessments.

Companies and brands in our research universe in Tunisia

Research projects we field in Tunisia regularly cover the competitive sets of category leaders such as global pharmaceutical companies with local presence like Sanofi, Pfizer, and AstraZeneca.

We also study local and regional players in various health-related sectors.

The brands and organizations whose categories shape our research scope in Tunisia include Tunisie Telecom, Orange, Ooredoo (telecom and digital health), Société Tunisienne de Banque, Attijari Bank, BIAT (financial services impacting health expenditures), and major food producers like Délice Danone and Vitalait.

We also encounter brands from the broader consumer market like SAH (Sanita) and Monoprix.

Our work also considers the context set by local industrial groups like Poulina Group Holding and Mabrouk Group, which have diverse interests including healthcare and food. We analyze the market presence of energy providers such as TotalEnergies and Vivo Energy (Shell).

Our epidemiology research in epidemiology market research company in Morocco also provides insights on a similar regional environment.

Why teams choose Global Vox Populi as their Epidemiology market research company in Tunisia

Our Tunisia desk operates with senior researchers who average 15+ years of experience in healthcare and epidemiology studies.

  1. We offer in-house translation and back-translation capabilities by native speakers of both Tunisian Arabic and French, delivering accuracy.
  2. Clients work with a single project lead from the initial brief through final debrief, delivering continuity and clear communication.
  3. We deliver anonymized epidemiological datasets and detailed analytical reports, providing direct inputs for strategic planning.

Frequently Asked Questions

Q: What kinds of clients commission epidemiology research in Tunisia?

A: Clients commissioning epidemiology research in Tunisia typically include pharmaceutical companies, medical device manufacturers, healthcare providers, and government health agencies. They seek data on disease prevalence, patient journeys, and treatment outcomes to inform product development, market access strategies, and public health policies. Our work supports both commercial and public health objectives.

Q: How do you deliver sample quality for Tunisia’s diverse population?

A: We deliver sample quality through a multi-pronged approach, including using verified HCP panels, working with patient advocacy groups under strict ethical guidelines, and implementing reliable screening protocols. Our methods account for urban-rural disparities and socio-economic variations, striving for representative data across Tunisia’s diverse population segments. We apply strict quota controls.

Q: Which languages do you cover in Tunisia?

A: We cover both official and commonly used business languages in Tunisia. Our fieldwork, moderation, and reporting capabilities extend to both Tunisian Arabic and French. This makes sure we can effectively communicate with a broad range of healthcare professionals and patients, capturing nuanced insights without linguistic barriers.

Q: How do you reach hard-to-find audiences (HCPs, specific patient groups) in Tunisia?

A: Reaching hard-to-find audiences involves strategic partnerships with local medical associations and specialized patient networks. We employ targeted recruitment through professional databases and referential sampling for rare patient conditions. Our field teams are experienced in engaging busy healthcare professionals and sensitive patient groups with appropriate protocols. Our market research companies in Tunisia umbrella services also benefit from these networks.

Q: What is your approach to data privacy compliance under Tunisia’s framework?

A: We adhere strictly to Tunisia’s Law No. 2004-63 on the Protection of Personal Data. Our approach includes explicit informed consent, reliable data anonymization or pseudonymization, and secure data storage within the country or compliant international servers. We make sure participants are fully aware of their rights, including data access and withdrawal, throughout the research process.

Q: Can you combine epidemiology research with other methods (e.g., qualitative interviews, quantitative surveys)?

A: Yes, we frequently combine epidemiology research with other methods to provide a more holistic view. For instance, quantitative prevalence studies might be augmented with qualitative in-depth interviews with key opinion leaders or patient focus groups to understand underlying perceptions and experiences. This mixed-method approach enriches the findings considerably.

Q: How do you manage cultural sensitivity in Tunisia?

A: Managing cultural sensitivity in Tunisia is essential. Our local teams are deeply familiar with cultural norms and social etiquette, particularly when discussing health-related topics. We train our interviewers to approach sensitive subjects with respect and discretion, making sure question wording and fieldwork approaches are culturally appropriate. All materials are localized by native speakers.

Q: Do you handle both patient and HCP epidemiology research in Tunisia?

A: Yes, we conduct epidemiology research targeting both patient populations and healthcare professionals (HCPs) in Tunisia. This includes studies on patient journeys, quality of life, and treatment adherence, as well as HCP studies on prescribing patterns, diagnostic practices, and unmet needs. Our expertise spans the entire healthcare network.

Q: What deliverables do clients receive at the end of an epidemiology project in Tunisia?

A: Clients receive a range of deliverables tailored to their needs. These typically include comprehensive reports detailing methodology and findings, anonymized raw datasets, statistical analyses, and executive summaries. We also provide debrief presentations, often including actionable recommendations. All outputs are designed for direct application to strategic decisions.

Q: How do you handle quality assurance and back-checks for epidemiology data?

A: Quality assurance for epidemiology data involves multiple checks. We implement logical consistency checks during data collection and conduct back-checks on a percentage of completed surveys to verify data accuracy. Our statistical validation processes identify outliers or anomalies, delivering the reliability of prevalence and incidence estimates. Field supervisors also monitor data collection in real-time.

When your next research brief involves Tunisia, let’s talk through it. Request A Quote or View Case Studies from our work.

Request research

Let's begin

Ready to hear what your market actually thinks?

Tell us the decision you're trying to make. We'll come back with what we'd field — usually within four business hours.

Brief us on a study